Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Duke Energy
DUK
$93.4B
| $277K | ﹤0.01% |
3,138
+182
| +6% | +$16.1K |
|
977
Lincoln National
LNC
$8.07B
| $277K | ﹤0.01% |
4,293
-27,519
| -87% | -$1.76M |
|
|
HUD
978
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $275K | ﹤0.01% |
19,909
-60,697
| -75% | -$888K |
|
979
Spire
SR
$4.78B
| $274K | ﹤0.01% |
3,260
+82
| +3% | +$6.87K |
|
|
PCMI
980
DELISTED
PCM, Inc
PCMI
| $274K | ﹤0.01% |
7,820
+335
| +4% | +$9.88K |
|
981
Radian Group
RDN
$4.84B
| $272K | ﹤0.01% |
+11,899
| New | +$271K |
|
982
Ameriprise Financial
AMP
$49.1B
| $271K | ﹤0.01% |
+1,869
| New | +$270K |
|
983
Caleres
CAL
$457M
| $271K | ﹤0.01% |
+13,615
| New | +$315K |
|
|
TBI
984
Trueblue
TBI
$323M
| $271K | ﹤0.01% |
12,268
+3,360
| +38% | +$78K |
|
985
Howard Hughes
HHH
$3.97B
| $269K | ﹤0.01% |
2,275
-18
| -0.8% | -$1.84K |
|
986
W&T Offshore
WTI
$592M
| $268K | ﹤0.01% |
53,997
-50,029
| -48% | -$270K |
|
|
SHOE
987
Shoe Station Group
SHOE
$420M
| $266K | ﹤0.01% |
19,284
-25,702
| -57% | -$400K |
|
988
First Horizon
FHN
$11.7B
| $265K | ﹤0.01% |
17,731
+5,100
| +40% | +$73.8K |
|
989
Linde
LIN
$225B
| $263K | ﹤0.01% |
+1,309
| New | +$245K |
|
990
Fidelity National Financial
FNF
$12.7B
| $261K | ﹤0.01% |
+6,739
| New | +$254K |
|
|
GBT
991
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $261K | ﹤0.01% |
+4,953
| New | +$285K |
|
992
Upbound Group
UPBD
$1.1B
| $260K | ﹤0.01% |
+9,761
| New | +$232K |
|
993
Viavi Solutions
VIAV
$9.6B
| $260K | ﹤0.01% |
+19,563
| New | +$253K |
|
994
Brown-Forman Class B
BF.B
$13.1B
| $258K | ﹤0.01% |
+4,649
| New | +$248K |
|
995
Texas Capital Bancshares
TCBI
$4.27B
| $258K | ﹤0.01% |
+4,199
| New | +$255K |
|
996
EPR Properties
EPR
$4.62B
| $257K | ﹤0.01% |
3,439
+194
| +6% | +$15.1K |
|
997
Markel Group
MKL
$22.2B
| $255K | ﹤0.01% |
+234
| New | +$245K |
|
|
AKCA
998
DELISTED
Akcea Therapeutics Inc
AKCA
| $254K | ﹤0.01% |
+10,829
| New | +$267K |
|
999
KKR & Co
KKR
$97.4B
| $253K | ﹤0.01% |
+10,029
| New | +$240K |
|
1000
Scholastic
SCHL
$757M
| $253K | ﹤0.01% |
+7,598
| New | +$283K |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.